1. Home
  2. FFBC vs ACAD Comparison

FFBC vs ACAD Comparison

Compare FFBC & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bancorp.

FFBC

First Financial Bancorp.

HOLD

Current Price

$34.49

Market Cap

3.6B

Sector

Finance

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$26.22

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFBC
ACAD
Founded
1863
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.8B
IPO Year
2004
2000

Fundamental Metrics

Financial Performance
Metric
FFBC
ACAD
Price
$34.49
$26.22
Analyst Decision
Buy
Buy
Analyst Count
8
22
Target Price
$30.71
$30.55
AVG Volume (30 Days)
1.0M
1.8M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
3.34%
N/A
EPS Growth
10.83
69.12
EPS
0.71
0.02
Revenue
N/A
$726,437,000.00
Revenue This Year
$27.67
$18.80
Revenue Next Year
$4.58
$11.70
P/E Ratio
$47.90
$1,320.00
Revenue Growth
N/A
40.45
52 Week Low
$23.09
$19.69
52 Week High
$35.00
$28.35

Technical Indicators

Market Signals
Indicator
FFBC
ACAD
Relative Strength Index (RSI) 65.20 74.40
Support Level $29.32 $25.40
Resistance Level $35.00 $27.79
Average True Range (ATR) 0.71 0.94
MACD 0.01 0.23
Stochastic Oscillator 85.30 82.17

Price Performance

Historical Comparison
FFBC
ACAD

About FFBC First Financial Bancorp.

First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending, and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and non-interest-bearing accounts, time deposits, and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

Share on Social Networks: